Abstract
Edoxaban is an orally active, direct factor Xa inhibitor indicated to reduce the risk of stroke and systemic embolism in non-valvular atrial fibrillation and for the treatment of venous thromboembolism. This study assessed the pharmacokinetics, safety, and tolerability of the edoxaban 60-mg tablet crushed and administered via a nasogastric tube in a water suspension or orally mixed in apple puree. This phase 1, open-label, crossover study randomized 30 healthy adults to receive three edoxaban treatment regimens (oral 60-mg edoxaban tablet, or 60-mg edoxaban tablet crushed and administered via a nasogastric tube or orally in apple puree) in one of six treatment sequences. Total edoxaban exposure was similar between the intact and crushed tablet regimens (mean area under the plasma concentration-time curve from time zero to infinity: whole tablet, 2132 ng·h/mL; nasogastric tube, 2021 ng·h/mL; apple puree, 2076 ng·h/mL). Mean maximum plasma concentration, area under the plasma concentration-time curve from time zero to the time of the last measurable concentration, terminal half-life, and apparent total body clearance values were also similar. Time to maximum plasma concentration was significantly shorter for the nasogastric tube ...Continue Reading
References
Jan 1, 1991·Dysphagia·S Lindgren, L Janzon
Mar 17, 1990·BMJ : British Medical Journal·B R BloemA R Wintzen
Mar 30, 2005·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Patricia Cornish
Jan 19, 2010·Journal of Clinical Pharmacology·Koichiro OgataSatoshi Kunitada
Jun 11, 2010·Journal of Clinical Pharmacology·Jeanne MendellSatoshi Kunitada
May 28, 2011·Journal of Advanced Nursing·Jennifer KellyJohn Wood
Oct 12, 2012·European Journal of Clinical Pharmacology·Julia T SchieleWalter E Haefeli
May 15, 2015·Journal of Clinical Pharmacology·Dolly A ParasrampuriaSatoshi Kunitada
May 27, 2015·Journal of Clinical Pharmacology·Jeanne MendellShuquan Chen
Jul 21, 2015·Clinical Therapeutics·Yan SongFrank LaCreta
Dec 2, 2015·Clinical Pharmacokinetics·Dolly A Parasrampuria, Kenneth E Truitt
Oct 1, 2013·Clinical Pharmacology in Drug Development·Nobuko MatsushimaJeanne Mendell
Jul 1, 2014·Clinical Pharmacology in Drug Development·Kenneth T MooreLarry E Fields
Jun 14, 2016·Clinical Therapeutics·Yan SongCharles Frost
Citations
Mar 23, 2019·Expert Review of Cardiovascular Therapy·Carlos Escobar CervantesVivencio Barrios
Jun 7, 2020·Drugs·Alberto CorsiniGiuseppe Boriani
Sep 13, 2020·American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions·Rami A Al-Horani
Mar 22, 2018·European Heart Journal·Jan SteffelUNKNOWN ESC Scientific Document Group
Jan 14, 2021·Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners·Victoria R Nachar, Allison J Schepers
Nov 14, 2020·Journal of Cardiovascular Medicine·Domenico D'AmarioFilippo Crea
Apr 26, 2021·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Jan SteffelUNKNOWN External reviewers
May 7, 2021·Deutsche medizinische Wochenschrift·Daniel DürschmiedChristoph Bode
Aug 28, 2021·International Journal of Molecular Sciences·Grzegorz GrześkJoanna Banach
Nov 19, 2021·European Heart Journal·UNKNOWN Task Force for the management of COVID-19 of the European Society of Cardiology
Dec 6, 2021·Cardiovascular Research·UNKNOWN Task Force for the management of COVID-19 of the European Society of Cardiology